Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model

Past clinical trials of adjuvant therapy combined with interferon (IFN) alpha, fluorouracil, cisplatin, and radiation improved the 5‐year survival rate of pancreatic ductal adenocarcinoma (PDAC). However, these trials also revealed the disadvantages of the systemic toxicity of IFN and insufficient d...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinoda, Shuhei, Sharma, Nikita S., Nakamura, Naohiko, Inoko, Kazuho, Sato‐Dahlman, Mizuho, Murugan, Paari, Davydova, Julia, Yamamoto, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475772/
https://www.ncbi.nlm.nih.gov/pubmed/37439437
http://dx.doi.org/10.1111/cas.15903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475772/
https://www.ncbi.nlm.nih.gov/pubmed/37439437
http://dx.doi.org/10.1111/cas.15903

Ejemplares similares